Delivery Order SPE2DB22D2007-SPE2DB25FJ4BM
Award Date 8/19/25
Potential Completion Date 8/20/25
Potential Value $3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Visipaque 320 mg/ml infusion bottles (150 ml units) with a ceiling value of $4,126.40. This firm fixed-price delivery order, which is expected to be completed by August 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 billion through December 2026. The award was...
- The Defense Logistics Agency awarded a $5,006.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Visipaque 320 mg/ml in 100 ml bottles. This contract, with an ultimate completion date of August 8, 2025, represents a non-set-aside competitive award for pharmaceutical procurement supporting federal medical supply needs. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,038.55 to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/mL infusion bottles (150 mL units). This firm fixed-price delivery order, awarded on August 15, 2025, represents a non-competitive set-aside procurement and will be fulfilled by AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. Visipaque is a contrast medium used in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $2,002.68, for Visipaque 320 mg/ml in a 100 ml bottle. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, issued on July 29, 2025. The award is non-competitive set-aside and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $5,006.70 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Visipaque 320 mg/mL in 100 mL bottles. The contract, which represents a non-set-aside, competitively awarded delivery order, is scheduled for ultimate completion by August 14, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Visipaque is a contrast media used in diagnostic imaging...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $32,271.62 by the Medical Supply Chain, a component of the Department of Defense, for the supply of Visipaque 320 mg/ml in 100 ml bottles. This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 14, 2025, and represents a non-set-aside procurement. The contract was executed on August 13, 2025, with performance to take place at AmerisourceBergen's corporate office location in...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,140.32 firm-fixed-price delivery order is for the supply of 150 mL bottles of Visipaque 320 mg/mL, a contrast agent used for medical imaging. The contract does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,650.56 contract is for the delivery of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a specialty pharmaceutical product. The contract has an ultimate completion date of February 7, 2025 and is a firm fixed price delivery order with no set-aside designation. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VISIPAQUE 320 MG/ML INFUS BTL 150ML, a pharmaceutical product. The award has a potential value of $4,219.10 and a completion date of February 6, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations for this contract. This delivery order is issued under an indefinite delivery...
- This federal contract award, valued at $1,650.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a medical product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...